Healthcare provider profile · identity verified

Michael Hendrixson, DO

Internal Medicine · WEST CHESTER, OH · NPI 1114966744

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	583	148
Levothyroxine Sodium	Levothyroxine Sodium	560	127
Lisinopril	Lisinopril	418	111
Amlodipine Besylate	Amlodipine Besylate	417	106
Omeprazole	Omeprazole	325	79
Losartan Potassium	Losartan Potassium	222	63
Metoprolol Succinate	Metoprolol Succinate	221	51
Gabapentin	Gabapentin	217	49
Rosuvastatin Calcium	Rosuvastatin Calcium	208	60
Simvastatin	Simvastatin	194	53
Hydrochlorothiazide	Hydrochlorothiazide	184	46
Tamsulosin Hcl	Tamsulosin Hcl	184	48
Metformin Hcl	Metformin Hcl	182	48
Pantoprazole Sodium	Pantoprazole Sodium	157	42
Eliquis	Apixaban	150	24
Metformin Hcl Er	Metformin Hcl	148	39
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	130	35
Trazodone Hcl	Trazodone Hcl	128	29
Olmesartan Medoxomil	Olmesartan Medoxomil	124	34
Pravastatin Sodium	Pravastatin Sodium	123	35
Alprazolam	Alprazolam	122	20
Metoprolol Tartrate	Metoprolol Tartrate	117	27
Atenolol	Atenolol	112	27
Zolpidem Tartrate	Zolpidem Tartrate	112	17
Albuterol Sulfate Hfa	Albuterol Sulfate	111	36
Fluticasone Propionate	Fluticasone Propionate	93	22
Clonazepam	Clonazepam	91	13
Sertraline Hcl	Sertraline Hcl	88	28
Allopurinol	Allopurinol	87	24
Escitalopram Oxalate	Escitalopram Oxalate	87	18
Glipizide Er	Glipizide	87	19
Ozempic	Semaglutide	82	12
Methylprednisolone	Methylprednisolone	81	66
Azithromycin	Azithromycin	78	69
Duloxetine Hcl	Duloxetine Hcl	72	20
Furosemide	Furosemide	72	22
Montelukast Sodium	Montelukast Sodium	71	19
Lorazepam	Lorazepam	64	13
Citalopram Hbr	Citalopram Hydrobromide	61	19
Famotidine	Famotidine	60	11
Sumatriptan Succinate	Sumatriptan Succinate	57	suppressed
Prednisone	Prednisone	56	22
Meloxicam	Meloxicam	55	16
Valsartan	Valsartan	54	14
Carvedilol	Carvedilol	52	13
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	52	13
Trulicity	Dulaglutide	51	11
Celecoxib	Celecoxib	49	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	13
Glimepiride	Glimepiride	48	11
Nystatin	Nystatin	47	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	46	41
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	12
Promethazine Hcl	Promethazine Hcl	45	suppressed
Clopidogrel	Clopidogrel Bisulfate	44	15
Glipizide	Glipizide	44	suppressed
Potassium Chloride	Potassium Chloride	44	13
Fluoxetine Hcl	Fluoxetine Hcl	43	13
Ropinirole Hcl	Ropinirole Hcl	43	suppressed
Jardiance	Empagliflozin	39	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	38	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	11
Warfarin Sodium	Warfarin Sodium	38	suppressed
Diazepam	Diazepam	37	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	37	suppressed
Spironolactone	Spironolactone	37	suppressed
Diclofenac Sodium	Diclofenac Sodium	35	11
Bupropion Xl	Bupropion Hcl	34	suppressed
Nifedipine Er	Nifedipine	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	20
Amoxicillin	Amoxicillin	32	22
Memantine Hcl	Memantine Hcl	32	suppressed
Synthroid	Levothyroxine Sodium	31	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	29	suppressed
Finasteride	Finasteride	29	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Ventolin Hfa	Albuterol Sulfate	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	17
Benazepril Hcl	Benazepril Hcl	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	18
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	22	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Rizatriptan	Rizatriptan Benzoate	20	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	18	suppressed
Olanzapine	Olanzapine	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Topiramate	Topiramate	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Cephalexin	Cephalexin	17	13
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Temazepam	Temazepam	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Trospium Chloride	Trospium Chloride	17	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Unifine Pentips	Pen Needle, Diabetic	16	suppressed
Zenpep	Lipase/Protease/Amylase	16	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Humalog Kwikpen U-200	Insulin Lispro	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Tresiba Flextouch U-200	Insulin Degludec	15	suppressed
Estradiol	Estradiol	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	12
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Prazosin Hcl	Prazosin Hcl	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Lactulose	Lactulose	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error